EFFECTIVENESS OF TIOTRIAZOLINE IN COMPLEX THERAPY OF ISCHEMIC HEART DISEASE

QR Code

EFFECTIVENESS OF TIOTRIAZOLINE IN COMPLEX THERAPY OF ISCHEMIC HEART DISEASE

Aim. To study molecular effects of tiotriazoline in 30 patients with stable angina I-III functional class.Material and methods. Comparison of molecular effects of cardioprotection is done based on dynamics of exercise tolerance dynamics, and via proteomic methods of investigation, questionnaires ass...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. A. Kartashova, A. A. Kastanyan, M. I. Nazheva, A. Yu. Zhulitov, E. I. Zheleznyak
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2016-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	tiotriazoline ischemic heart disease exercise tolerance cytochemistry proteomics
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/409
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASE
by: E. A. Kartashova
Published: (2009-10-01)

The chemistry of living cells /
by: Downes, Helen R.
Published: (1962)

NITRATES IN ISCHEMIC HEART DISEASE TREATMENT, YESTERDAY AND TODAY
by: S. N. Tereschenko, et al.
Published: (2015-12-01)

Cells and energy /
by: Goldsby, Richard A.
Published: (1967)

Post-Exercise Hypotension Induced by a Short Isometric Exercise Session Versus Combined Exercise in Hypertensive Patients with Ischemic Heart Disease: A Pilot Study
by: Matteo Vitarelli, et al.
Published: (2025-05-01)

THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

THE SPECIFICS OF ISCHEMIC HEART DISEASE MANAGEMENT IN ELDERLY
by: F. I. Belyalov
Published: (2017-03-01)

Submicroscopic cytochemistry /
by: Gersh, Isidore, 1907-
Published: (1973)

Long-term effects of enhanced external counterpulsation in the management of patients with ischemic chronic heart failure
by: A. S. Lishuta, et al.
Published: (2024-06-01)

Effect of Different Isometric Exercise Modalities on Myocardial Work in Trained Hypertensive Patients with Ischemic Heart Disease: A Randomized Pilot Study
by: Giuseppe Caminiti, et al.
Published: (2025-03-01)

COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES
by: A. N. Sumin, et al.
Published: (2017-11-01)

Perioperative period in heart transplantation with extremely prolonged ischemic times (>6 hours)
by: V. N. Poptsov, et al.
Published: (2022-09-01)

ANTIISCHEMIC METABOLIC MODULATOR TRIMETAZIDINE IN TREATMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2017-02-01)

Ischemic heart disease and reflux-esophagitis: complexities of the differential diagnosis and treatment.
by: Yu. N. Belenkov, et al.
Published: (2011-05-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease
by: E. I. Tarlovskaya, et al.
Published: (2016-03-01)

NEBIVOLOL SAFETY AS CARDIOSELECTIVE Β-BLOCKER IN COMPLEX THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE ACCOMPANIED BY CHRONIC OBSTRUCTIVE BRONCHITIS
by: Zh. G. Simonova, et al.
Published: (2003-10-01)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

EFFECTS OF ENALAPRIL ON ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. I. Katelnizkaya, et al.
Published: (2016-01-01)

The effect of use simvastatin at treatment of ischemic heart disease patients of senile age
by: A. L. Pirogov, et al.
Published: (2007-10-01)

ISCHEMIC HEART DISEASE AND SPECIFICS OF PERIPHERAL MICROCIRCULATION IN VARIOUS AGE GROUPS
by: O. V. Kamenskaya, et al.
Published: (2014-08-01)

STENOSIS IN NONCORONARY AREAS AND LIFE QUALITY IN ISCHEMIC HEART DISEASE
by: A. N. Sumin, et al.
Published: (2015-07-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-12-01)

USE OF AFM FOR MORPHO-FUNCTIONAL STATE DIAGNOSTICS OF PLATELETS OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. V. Kukharenko, et al.
Published: (2019-06-01)

ENDOTHELIAL DYSFUNCTION AND “OXIDATIVE STRESS” BY THE NONNSTABLE COURSE OF ISCHEMIC HEART DISEASE
by: A. E. Kratnov, et al.
Published: (2014-07-01)

COMPARATIVE ANALYSIS OF THE CALCULATION MODELS FOR ISCHEMIC HEART DISEASE OVERALL RISK IN RAILROAD WORKERS
by: S. G. Gorokhova, et al.
Published: (2016-06-01)

Effect of acupuncture on cardiac function improvement in patients with heart failure: A series of case reports
by: Biao Luo, et al.
Published: (2025-08-01)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: N. Yu. Shimohina, et al.
Published: (2017-03-01)

ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES
by: Y. A. Karpov
Published: (2015-12-01)

A case of successful conservative therapy of patient with severe heart failure caused by ischemic heart disease: case report
by: M. T. Beishenkulov, et al.
Published: (2022-05-01)

ANTIARRHYTHMIC ACTION OF CARDIOCYTOPROTECTORS IN TREATMENT OF ISCHEMIC HEART DISEASE WITH VENTRICULAR ARRHYTHMIAS
by: E. A. Ryngach, et al.
Published: (2016-09-01)

A LIFE-EXHAUSTION: INTERRELATION WITH THE PREVALENCE OF ISCHEMIC HEART DISEASE
by: M. M. Kayumova, et al.
Published: (2014-08-01)

A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Elaboration of New Medical Technology for Predicting the Risk of Ischemic Heart Disease in the Workers of the Coal Industry
by: N. I. Panev, et al.
Published: (2019-07-01)

PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
by: N. Yu. Karpova, et al.
Published: (2015-09-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
by: A. I. Chesnikova, et al.
Published: (2016-01-01)